Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor
Authors:
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 10 (3) , 546-556
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273465, 30825045)
This publication has 38 references indexed in Scilit:
- Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of NanoparticlesScience, 2013
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJournal of Pharmacy and Pharmacology, 2013
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Nanoparticle PEGylation for Imaging and TherapyNanomedicine, 2011
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer DrugsScience, 2010
- Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivoInternational Journal of Pharmaceutics, 2008
- Exploiting the enhanced permeability and retention effect for tumor targetingDrug Discovery Today, 2006
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006
- Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeuticsThe FASEB Journal, 2005
- Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinomaJournal of Hepatology, 2004